Christian T. Farrar1, Gregory Tesz2, and Jeremy Wellen2
1Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, United States, 2Pfizer Worldwide Research & Development, Cambridge, MA, United States
Synopsis
In this study, 31P-MRS
was applied to monitor hepatic fructose metabolism of rats in response to IV
fructose challenge. Animals exposed to
7-days of sucrose-enriched diet experienced enhanced fructose clearance
relative to animals on an isocaloric control diet. The finding of more efficient fructose
metabolism in the sucrose fed group corresponded with elevated KHK and AldoB
gene expression, two key enzymes responsible for fructose clearance. Treatment of animals on sucrose diet with a
KHK inhibitor nearly completely blocked fructose metabolism and prevented
increased expression of these enzymes, implying that metabolism of fructose
elicits the enzyme induction rather than fructose itself.
Introduction
Fructose is a nearly
ubiquitous component of the modern Western diet, and its consumption is argued
to be a contributing factor to the rise in prevalence of obesity that afflicts
roughly one-third the population of developed countries (1). Given the wide range of comorbidities
associated with obesity and their cumulative economic and psychosocial
implications, identifying viable options to reverse disease progression remains
a significant healthcare need. One strategy
could entail modulating the metabolic effects associated with dietary intake of
fructose. Fructose metabolism is not subject
to the same level of regulatory feedback inhibition as glucose metabolism;
therefore fructose more readily enters the glycolytic pathway, facilitating de novo lipogenesis (DNL) and the
accumulation of fat in storage depots such as the liver and adipose tissue (2). Metabolic enzyme expression is regulated
through a network of factors that respond to both hormonal and nutrient
status. In the case of fructose, metabolism
is initiated by ketohexokinase (KHK) mediated phosphorylation of fructose to
fructose-1-phosphate (F-1-P), which is further metabolized by aldolase B
(AldoB), progressing through a series of intermediate metabolites prior to
entering the glycolytic pathway. 31P-MRS
has previously been applied to monitor the kinetics of fructose metabolism in
the liver in response to IV fructose challenge by quantifying spectral change
in the phosphomonoester peak (PME), which is attributed to change in F-1-P
concentration (3). Here we report
findings from a mechanistic study of the effects of chronic sucrose consumption on enzyme activity in rats as assessed by dynamic in vivo 31P-MRS of the
liver. Methods
Adult Sprague-Dawley rats (male, 225-250g,
~8-weeks old) were maintained on either normal chow or an isocaloric sucrose diet
consisting of 30% sucrose (D13032001, ResearchDiets) for a period of 7-days
(N=6 per diet group). A separate group
of rats (N=6) was treated with an inhibitor of KHK (30 mg/kg/day, PO) while on sucrose
diet. Acquisition of 31P-spectra
of rat liver was optimized on a Bruker Biospec 9.4T/20 to enable longitudinal
tracking of fructose metabolism following IV administration of fructose bolus. A custom fabricated Tx/Rx 31P RF surface
coil designed to rest under the abdomen of prone positioned rats and a standard
pulse-acquire sequence with TR=3000 msec, SW=10 kHz, and NA=100 was used to
dynamically acquire spectra with a temporal resolution of 5-minutes. In preparation for scanning, overnight fasted
animals were anesthetized under isoflurane and a tail vein catheter was placed
for in-bore administration of fructose solution (20% w/v, 500mg/kg). Baseline 31P-spectra were
acquired, and post‑fructose metabolic response was followed through the
collection of additional spectra over a period of 30-minutes. Difference spectra were generated by
subtracting the average of the baseline spectra from the post-fructose spectra,
and ΔPME response was quantified by
calculating the area of the PME region (iNMR, MestreLab Research, S.L.). A separate study was conducted with identical
treatment groups and duration to quantify alterations in gene expression. Following the 7-day treatment period, animals
were fasted overnight, sacrificed, and hepatic RNA was isolated for gene
expression analysis by qRT-PCR. Results
A stacked-plot time-series of
spectra from an example dynamic run with a control diet animal is provided in
Fig. 1A, along with representative plots of ΔPME
response from animals of each study group in Fig. 1B. From the calculated ΔPME AUC values provided in Fig. 2A, it is noted that the chronic
sucrose diet resulted in a statistically significant reduction in AUC relative
to animals on normal chow (p<0.005), while the addition of a KHK inhibitor
to the diet regimen resulted in a further reduction in ΔPME AUC. KHK and AldoB expression
profiles from harvested livers of each treatment group are provided in Fig. 2B
and demonstrate elevated levels in the sucrose diet group, and that inhibition
of fructose metabolism prevented the induction of enzyme expression.Discussion
Data from this study
suggests that 7-days of elevated sucrose ingestion promoted hepatic expression
of KHK and AldoB, the two key enzymes responsible for fructose clearance. Induction of these enzymes facilitates the
efficient metabolism of fructose, which is evident from the reduced ΔPME
AUC observed in sucrose fed animals. In
order to better discern if fructose itself or a metabolite of fructose promotes
induction of these enzymes, a group of animals was treated with a KHK inhibitor
while on the sucrose diet. Treatment
with the KHK inhibitor nearly completely blocked fructose metabolism, as indicated
by a ~75% reduction in DPME AUC relative to control diet animals. Additionally, the induction of KHK and AldoB
was completely suppressed in the KHK inhibitor treated group, suggesting that
fructose metabolism is required for increased enzyme expression. Acknowledgements
No acknowledgement found.References
1. NCD Risk Factor Collaboration.
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based
measurement studies with 19.2 million participants. Lancet 2016: 387:1377-1396.
2. Sun SZ, et al. Fructose metabolism in humans – what isotopic tracer studies
tell us. Nutr Metab 2012; 9:89.
3. Boesiger P, et al. Changes
of liver metabolite concentrations in adults with disorders of fructose
metabolism after intravenous fructose by 31P magnetic resonance
spectroscopy. Pediatr. Res. 1994; 36:436-440.